(Q75230690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Peter J Meikle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Allison Crawley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Steven L Ramsay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

JohnJ Hopwood

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

7 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

585-591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14711884%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1203/01.pdr.0000113789.30640.5c

17 November 2019

exact match

0 references

cites work

Prevalence of lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme-replacement therapy in mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement and enhancement therapies: lessons from lysosomal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement in a canine model of Hurler syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement therapy in feline mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement with recombinant beta-glucuronidase in the newborn mucopolysaccharidosis type VII mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement therapy for murine mucopolysaccharidosis type VII

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Advantages of using same species enzyme for replacement therapy in a feline model of mucopolysaccharidosis type VI

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Urinary excretion of sulphated N-acetylhexosamines in patients with various mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C

Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000113789.30640.5C